Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Inhibition of Endogenous Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis by Inducing Myeloid-Derived Suppressor Cells.
Guideline for the diagnosis and management of multiple sclerosis in children.
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis.
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
Clinical features of Chinese patients with multiple sclerosis with aquaporin-4 antibodies in cerebrospinal fluid but not serum.
Acute transverse myelitis (ascending myelitis) as the initial manifestation of Japanese encephalitis: a rare presentation.
BG-12 in Multiple Sclerosis.
Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.
Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis.
Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.
IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
Sequencing the immunopathologic heterogeneity in multiple sclerosis.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature.
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation.
Hesperidin, a Citrus Flavonoid, Has the Ameliorative Effects Against Experimental Autoimmune Encephalomyelitis (EAE) in a C57BL/J6 Mouse Model.
How embodied is action language? Neurological evidence from motor diseases.
Early predictors of multiple sclerosis after a typical clinically isolated syndrome.
SJL Mice Infected with Acanthamoeba castellanii Develop Central Nervous System Autoimmunity through the Generation of Cross-Reactive T Cells for Myelin Antigens.
Demographic characteristics of MS patients in Poland's Upper Silesia region.
Spinal cord lesions and disability in Hispanics with multiple sclerosis.
Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
Stress in Multiple Sclerosis: Review of New Developments and Future Directions.
Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems.
Pages
« first
‹ previous
…
465
466
467
468
469
470
471
472
473
…
next ›
last »